The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.
about
Binding and killing of bacteria by bismuth subsalicylateCampylobacter pylori and gastroduodenal disease.Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pyloriStandardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori.Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazineCampylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrateEvaluation of liquid media for growth of Helicobacter pylori.The antibody titers to Helicobacter pylori in 7 - 12 year old iron deficiency anemic children, in Ilam.Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases.In vitro synergy testing of clarithromycin and 14-hydroxyclarithromycin with amoxicillin or bismuth subsalicylate against Helicobacter pyloriGuinea pig model for antibiotic transport across gastric mucosa: inhibitory tissue concentrations of clindamycin against Helicobacter pylori (Campylobacter pylori) following two separate dose regimens.In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.Eradication of Helicobacter pylori: therapies and clinical implications.Helicobacter pylori detection and antimicrobial susceptibility testing.Local gastric and serum amoxicillin concentrations after different oral application forms.Role of metronidazole resistance in therapy of Helicobacter pylori infections.Long-term colonization with single and multiple strains of Helicobacter pylori assessed by DNA fingerprinting.Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents.Bactericidal effect of amoxicillin on Helicobacter pylori in an in vitro model using epithelial cells.Characterization of an unclassified microaerophilic bacterium associated with gastroenteritisFailure of Campylobacter pylori to grow in commercial blood culture systemsEnhanced cultivation of Helicobacter pylori in liquid media.Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori.Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer.Secretion of intravenously administered antibiotics in gastric juice: implications for management of Helicobacter pylori.Activities of beta-lactams and macrolides against Helicobacter pylori.In vitro and in vivo activities of tea catechins against Helicobacter pylori.Antibacterial action of the urease inhibitor acetohydroxamic acid on Helicobacter pylori.Pharmacodynamic effects of nitroimidazoles alone and in combination with clarithromycin on Helicobacter pylori.Use of cryomicrotomy to study gastric diffusion of amoxicillin in guinea pigs.Pharmacodynamic effects of antibiotics and acid pump inhibitors on Helicobacter pyloriComparison of the nucleic acids of helical and coccoid forms of Helicobacter pylori.Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori.In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori)Bactericidal activity of antimicrobial agents against slowly growing Helicobacter pylori.Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.Evaluation of a rapid urease test to detect Campylobacter pylori infection.Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents.
P2860
Q24669770-A0B9B7C7-EFA4-4A13-9A79-0F28E99AD090Q30667514-72D87575-F6DC-4442-B2FB-08F9B6BFC9A3Q33697989-49398E79-9A3C-4115-9E5F-01F84F27B685Q33761162-72B7411A-A179-4A6E-8F43-D457E6E0C4BAQ33838835-CDC52410-0D21-4FF0-B30D-A4D15BFB70A3Q34288799-CBA07234-909C-493A-83CB-B2B644397285Q34379741-35C431B9-F854-4A11-9F16-F29668AAC6D1Q34532392-B9CFB0BB-2E17-45D6-A275-1221EE4B8619Q34580423-D6465837-0FE3-43FF-B3EB-6A9D3AD7D45BQ34864408-573846C7-30F8-426A-83F3-44F81B18985DQ35110775-C038E4D5-AC7F-415E-BD53-626D2D0F38ACQ35137399-B919A761-4EF9-4B6B-A940-14C4E9C79283Q35245350-790E7011-4CFE-4878-B9BB-71CE77DAE729Q35352378-6FDBB8AB-6A55-463B-8142-8D4244E549F6Q35531059-A9AFD01A-3FEA-48D0-8AF9-F54CFC85A81DQ35783436-5873E0FB-B429-4747-8761-395A9943A437Q35817181-FA55DF05-AB1B-4534-9BB4-26E94646D986Q35843554-B625E949-73B5-4130-8582-ACB4E2E1F110Q36520763-ACB5E42E-9F52-478F-A4F4-2DD19E5C4756Q36545248-7A8CD11A-018F-44A4-ABA2-82DF8871D007Q36753707-06AB01F3-F78C-4066-9838-8B7434343253Q37142506-FB6ED043-1FEA-448B-AE18-23D556154652Q37149530-F735ED4D-D7C8-406B-B0A7-7B6112E66DC4Q37239093-AC27C786-E76B-475C-B599-5B4795A5388BQ37242990-4F62F37A-4796-4985-B9DF-B559F4139F7CQ39225121-F9A623FE-D66D-45AC-B8C0-E06007C50E41Q39412420-C2D96708-F489-47EC-8E1F-F47479F1D541Q39470898-471A2218-7762-4B33-A5FE-7145F5621CB2Q39471347-5356B97F-8ABD-4541-BB7C-AC76E9B2D24FQ39612182-4715F124-CCF1-40B8-9B45-1068E2F2CBE6Q39652307-13C79AA8-C327-4649-9C8B-65E8030283FFQ39779423-09CE9D06-62D5-4A50-AEF9-F3BA4E66828AQ39785076-19979117-A6D0-4F13-BC27-8159B0BE4777Q39811217-1A0AE71A-4967-45CC-BF3C-0A7CFC8563FFQ39814822-91AE2C09-04C3-43B9-8623-71C6E2B8B99AQ39828752-E8165662-2378-4E96-99E6-ED0750DBB5F8Q39871004-DAA2C0C3-16AD-4E00-8D98-7AD4DF2B2631Q40086079-A5899E02-24C8-46F9-A9FD-D0E93B51C93BQ40194450-55E9BC8C-58E3-4DCC-A626-15726553BB56Q40283869-336BBFDD-387C-45B3-86E6-2683A1F816C4
P2860
The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
The minimum inhibitory and bac ...... ainst Campylobacter pyloridis.
@en
The minimum inhibitory and bac ...... ainst Campylobacter pyloridis.
@nl
type
label
The minimum inhibitory and bac ...... ainst Campylobacter pyloridis.
@en
The minimum inhibitory and bac ...... ainst Campylobacter pyloridis.
@nl
prefLabel
The minimum inhibitory and bac ...... ainst Campylobacter pyloridis.
@en
The minimum inhibitory and bac ...... ainst Campylobacter pyloridis.
@nl
P2093
P356
P1476
The minimum inhibitory and bac ...... ainst Campylobacter pyloridis.
@en
P2093
P304
P356
10.1093/JAC/17.3.309
P407
P577
1986-03-01T00:00:00Z